Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01028222
Title	A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Acronym	TEAM
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	melanoma
Therapies	Nilotinib
Age Groups:	adult
Covered Countries	USA \| SWE \| NLD \| ITA \| ESP \| DEU \| CHE \| CAN \| BRA \| BEL \| AUS \| ARG